Financial statements are reported in EUR and shown here converted to USD at today's exchange rate.
SNY — Sanofi
$48.37
$-0.09 (-0.19%)
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines.
Market Cap
$115.90B
Forward P/E
8.9x
52-Week Range
N/A
SNY Price History
Revenue vs. Net Income
$48.1B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$8B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
6.9%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.3x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
8.1%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-2.5%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
